
Swing
Stock Price Below SMA_5
Short Term
SMA_5 Above SMA_20
Mid Term
SMA_20 Below SMA_60
Long Term
SMA_60 Below SMA_200
The radar chart shows that buying NovaBay Pharmaceuticals Inc (NBY) stock in June has the highest probability of a positive return (55.56%), while February has the lowest probability (20.00%).
NBY's stock price fell by -91.18% in 2024,increased by 802.40% in 2025, and went down by 93.36%in 2026.
Bullish technical signals of NBY include: MOM_10 > 0, close > fibonacci_R1.
Bearish technical signals of NBY include: CCI_20_0.015 > 100, AO_5_34 < 0, MACD_12_26_9 < 0, STOCHRSIk_14_14_3_3 > 80, WILLR_14 > -20.
NBY has 2 buy signals and 5 sell signals now. Overall the technical rating for NBY is Sell. Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of NBY
NovaBay Pharmaceuticals Inc's overall moving average trend leans more bullish as of April 20 2026, with 2 negative signals and 2 positive signal.
The price prediction chart for NovaBay Pharmaceuticals Inc (NBY.A) stock, as of April 05 2026, forecasts a 12.98%% change over the next month, based on its high correlation with PTN stock patterns. The similarity between their price movements over the analyzed periods is 95.56%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
In Dec 2026, NovaBay Pharmaceuticals Inc's value is forecasted to reach an average price of $0.41. The price is predicted to fluctuate between a low of $0.30 and a high of $0.46.
In Dec 2030, NovaBay Pharmaceuticals Inc's value is forecasted to reach an average price of $0.16. The price is predicted to fluctuate between a low of $0.15 and a high of $0.20.